With 25 years of experience in drug development and biomanufacturing, Dr. Judy Chou is well recognized by the biomedical industry for her leadership and has received the Most Influential Women in Business Award in 2018. Before the current role as CEO and President of AltruBio, she headed the global Pharmaceutical Biotech organization at Bayer Pharmaceuticals overseeing the biotechnology product portfolio & 2000+ employees. Before Bayer, she held the role of Vice President of Pharmaceutical /Technical Operations at Pfizer, Inc., formerly Medivation. She was also Vice President of R&D at Tanvex Biopharma, Inc. Throughout Dr. Chou’s career, she has achieved significant milestones in protein therapeutic development and multiple filings of BLAs, NDAs, and INDs of novel products and is recognized for her work at Genentech, Wyeth, and Abbott. Before the industry, Dr. Chou was a research faculty member at Harvard University Medical School. She obtained her Ph.D. from Yale University.